Emerge Nuclear Software Can Diagnose Appropriate Use

Software can help determine when perfusion imaging is needed, even without obvious symptoms

 

July 30, 2012

Emerge Clinical Solutions, a creator of clinical decision support software, announced in July 2012 nuclear myocardial perfusion imaging (MPI) appropriateness update 3.1 that allows for diagnosis of both symptomatic and asymptomatic conditions.

Emerge’s real-time clinical decision solution helps doctors increase diagnosis efficiency and accuracy by filtering comprehensive patient data and history through the company’s rules engine and patented algorithms. The software has been proven to increase identification of certain cardiac diseases by as much as 300 percent. The Emerge rules engine performs more than 8,000 calculations in seconds to help doctors elect the most appropriate testing and procedures and choose a care path.

Emerge’s software simplifies the decision process and merges seamlessly with any electronic medical record (EMR), integrating in real-time. Its algorithms utilize appropriate use criteria and guidelines from the American College of Cardiology (ACC), American Health Association (AHA) and Heart Rhythm Society (HRS). The software exceeds stage 1 meaningful use requirements, as well as the proposed requirements of stages 2 and 3.

For more information: www.emergecds.com